# Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

> **NCT06403865** · — · NOT_YET_RECRUITING · sponsor: **University Paris 7 - Denis Diderot** · enrollment: 280 (estimated)

## Conditions studied

- Quality of Life

## Interventions

- **DRUG:** Cabotegravir, Rilpivirine Drug Combination

## Key facts

- **NCT ID:** NCT06403865
- **Lead sponsor:** University Paris 7 - Denis Diderot
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05
- **Primary completion:** 2026-04
- **Final completion:** 2026-10
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2024-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06403865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06403865, "Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06403865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*